Johnson & Johnson vs Pfizer Inc

Johnson & Johnson and Pfizer Inc both operate in the Healthcare sector, so comparing them is a choice between direct rivals: both are exposed to the same market forces, and the question is which handles them better.

This page puts both sets of numbers side by side. It does not declare a winner — VAQO is not an investment adviser — it arranges what you need to compare, instead of leaving you to open two pages and hold figures in your head.

Healthcare · Drug Manufacturers
$267.20
-0.71%
Day range: $266.73 – $270.10
Volume: 6.1M
Healthcare · Drug Manufacturers
$27.79
-0.02%
Day range: $27.57 – $27.98
Volume: 29.1M

What the numbers show

In the latest session Pfizer Inc (PFE) led with -0.02% against -0.71% for Johnson & Johnson (JNJ) — a gap of 0.70 percentage points.

JNJ vs PFE — frequently asked questions

How much do Johnson & Johnson and Pfizer Inc cost today?

Johnson & Johnson (JNJ) trades at $267.20 (-0.71%) and Pfizer Inc (PFE) at $27.79 (-0.02%) in the latest session.

What is the difference between Johnson & Johnson and Pfizer Inc?

Johnson & Johnson (JNJ) and Pfizer Inc (PFE) both operate in the Healthcare sector, so they are direct rivals exposed to the same market forces. The difference between them is performance and valuation, not what they do.

JNJ or PFE — which is better?

VAQO makes no recommendations and is not an investment adviser. What it provides is both sets of numbers side by side — price, daily move, volatility and risk scoring from a model whose accuracy is published openly — so the decision rests on a comparison rather than a feeling.

Related comparisons

This is not financial advice.

← All comparisons

Last updated: 2026-09-10